Increased cardiac troponin T and endothelin-1 concentrations in dialysis patients may indicate heart disease

Nephrology Dialysis Transplantation

Volumn 14, Issue 8, 1999, Pages 1948-1955

  Löwbeer, Christian ^b   Ottosson Seeberger, Astrid ^c   Gustafsson, Sven A ^c   Norrman, Rolf ^c   Hulting, Johan ^a   Gutierrez, Alberto ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c NONE

Author keywords

Cardiac markers; Creatine kinase isoenzymes; Endothelin; Left ventricular hypertrophy; Renal failure; Troponin

Indexed keywords

CREATINE KINASE MB; ENDOTHELIN 1; MARKER; TROPONIN T;

ADULT; AGED; ARTICLE; BLOOD LEVEL; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE INJURY; HEMODIALYSIS; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CREATINE KINASE; ENDOTHELIN-1; ENDOTHELINS; FEMALE; HEART DISEASES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; ISOENZYMES; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OSMOLAR CONCENTRATION; PERITONEAL DIALYSIS; PROTEIN PRECURSORS; RENAL DIALYSIS; TROPONIN T;

EID: 0344241923     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.8.1948     Document Type: Article

References (35)

1. European Transplantation and Dialysis Association: Report on Management of Renal Failure in Europe, XXIV, 1993. Nephrol Dial Transplant 1995; 10 [suppl 5]: 12
2. US Renal Data System: Causes of death. Annual Data Report. Bethesda, MD, The National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995; 14: 79-90
3. Rostrand RG, Kirk KA, Rutsky EA. Dialysis-associated ischemic heart disease: Insights from coronary angiography. Kidney Int 1984; 25: 653-659
4. Martin GS, Becker BN, Schulman G. Cardiac troponin-I accurately predicts myocardial injury in renal failure. Nephrol Dial Transplant 1998; 13: 1709-1712
5. Medeiros LJ, Schotte D, Gerson B. Reliability and significance of increased creatine kinase MB isoenzyme in the serum of uremic patients. Am J Clin Pathol 1987; 87: 103-108
6. Ohman EM, Armstrong PW, Christenson RH, GUSTO-IIa investigators. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med 1996; 335: 1333-1341
7. Müller-Bardorff M, Hallermayer K, Schröder A et al. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. Clin Chem 1997; 43: 458-466
8. Apple FS, Sharkey SW, Hoeft P et al. Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: a 1-year outcomes analysis. Am J Kidney Dis 1997; 29: 399-403
9. Haller C, Stevanovich A, Katus HA. Are cardiac troponins reliable serodiagnostic markers of cardiac ischaemia in end-stage renal disease? [Editorial comment]. Nephrol Dial Transplant 1996; 11: 941-944
10. Miyauchi T, Yanagisawa M, Tomizava T et al. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet 1989; 2: 53-54
11. Kiowski W, Sütsch G, Hunziker P et al. Evidence for endotheline-1-mediated vasoconstriction in severe chronic heart failure. Lancet 1995; 346: 732-736
12. Pernow J, Ahlborg G, Lundberg JM, Kaijser L. Long-lasting coronary vasoconstrictor effects and myocardial uptake of endothelin-1 in humans. Acta Physiol Scand 1997; 159: 147-153
13. Lerman A, Holmes DR, Bell MR Garratt KN, Nishimura RA, Burnett JC. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 1995; 92: 2426-2431
14. Mulder P, Richard V, Derumeaux G et al. Role of endogenous endothelin in chronic heart failure. Effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling. Circulation 1997; 96: 1976-1982
15. Koyama H, Tabata T, Nishzawa Y, Inoue T, Morii H, Yamaji T. Plasma endothelin levels in patients with uremia. Lancet 1989; 1: 991-992
16. Devereux RB, Alonso DR, Lutas EM et al. Echocardiografic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458
17. Casale P, Devereux R, Milner M et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Int Med 1986; 105: 173-178
18. Hemsén A, Ahlborg G, Ottosson Seeberger A, Lundberg JM. Metabolism of big endothelin-1 (1-38) and (22-38) in the human circulation in relation to production of endothelin-1 (1-21). Regul Pept 1995; 55: 287-297
19. Jaffe AS, Ritter C, Meltzer V, Harter H, Roberts R. Unmasking artifactual increases in creatine kinase isoenzymes in patients with renal failure. J Lab Clin Med 1984; 104: 193-202
20. Lindahl B, Venge P, Wallentin L, FRISC study group. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996; 93: 1651-1657
21. Bhayana V, Gougoulias T, Cohoe S, Henderson R. Discordance between results for serum troponin T and troponin I in renal disease. Clin Chem 1995; 41: 312-317
22. Willging S, Keller F, Steinbach G. Specificity of cardiac troponins I and T in renal disease. Clin Chem Lab Med 1998; 36: 87-92
23. Frankel WL, Herold DA, Ziegler TW, Fitzgerald RL. Cardiac troponin T is elevated in asymptomatic patients with chronic renal failure. Am J Clin Pathol 1996; 106: 118-123
24. McLaurin MD, Apple FS, Voss EM, Herzog CA, Sharkey SW. Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: evidence of cardiac troponin T expression in skeletal muscle. Clin Chem 1997; 43: 976-982
25. Haller C, Zehelein J, Remppis A, Müller-Bardorrf M, Katus HA. Cardiac troponin T in patients with end-stage renal disease: absence of expression in truncal skeletal muscle. Clin Chem 1998; 44: 930-938
26. Ricchiuti V, Voss EM, Ney A, Odland M, Anderson PAW, Apple FS. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim. Clin Chem 1998; 44: 1919-1924
27. Missov E, Calzolari C, Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 1997; 96: 2953-2958
28. Slaughter MR, McKinnon RR, Madra S et al. Myocardial cTnT immunoassay (Origen) as an early discriminator of physiological mechanisms of cardiac hypertrophy [Abstract]. Clin Chem 1998; 44: A106
29. Ottosson-Seeberger A, Ahlborg G, Hemsén A, Lundberg JM, Alvestrand A. Hemodynamic effects of endothelin-1 and big endothelin-1 in chronic hemodialysis patients. J Am Soc Nephrol 1999; 10: 1037-1044
30. Krüger D, Sheikhzadeh A, Giannitsis E, Stierle U. Cardiac release and kinetics of endothelin after severe short-lasting myocardial ischemia. J Am Coll Card 1997; 30: 942-946
31. Ishiye M, Umemura K, Uematsu T, Nakashima M. Angiotensin ATI receptor-mediated attenuation of cardiac hypertrophy due to volume overload: involvement of endothelin. Eur J Pharmacol 1995; 280: 11-17
32. Demuth K, Blacher J, Guerin AP et al. Endothelin and cardiovascular remodelling in end stage renal disease. Nephrol Dial Transplant 1998; 13: 375-383
33. Ooi DS, House AA. Cardiac troponin T in Hemodialyzed patients. Clin Chem 1998; 44: 1410-1416
34. Gunst JJ, Langlois MR, Delanghe JR, De Buyzere ML, Leroux-Roels GG. Serum creatine kinase activity is not a reliable marker for muscle damage in conditions associated with low extracellular glutathione concentration. Clin Chem 1998; 44: 939-943
35. Bonnefont-Rousselot D, Jaudon MC, Issad B et al. Antioxidant status of elderly chronic renal patients treated by continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1997; 12: 1399-1405